Navigation Links
Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
Date:3/31/2008

HOPKINTON, Mass., March 31 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today announced that the report of the Company's independent registered public accounting firm regarding the Company's 2007 financial statements contained an explanatory paragraph regarding the Company's ability to continue as a going concern. NASDAQ Marketplace Rules require NASDAQ-traded companies to publicly announce if their Annual Report on Form 10-K includes an audit report containing a going concern explanatory paragraph. For further information, please refer to the Company's Annual Report on Form 10-K filed on March 31, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initiatives. CETHRIN(R), a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potential
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Raises $5 Million
2. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
3. Barr Pharmaceuticals, Inc. Executive Bios
4. Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
5. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
6. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
7. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
8. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
9. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
10. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
11. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... News) -- Births of multiple babies cost more and ... births, researchers report. The researchers suggest that limiting ... could ease some of that burden. Over the ... with births to older mothers and use of assisted ... New South Wales, Australia. Their study, published online ...
(Date:9/15/2014)... 15, 2014 As Colorado's historic ... its first full year, there are a variety ... in the evolution of its marketing and branding. ... taken by Denver's Kindman, one of the state's ... , Kindman has pioneered the first-ever branded and ...
(Date:9/15/2014)... September 15, 2014 According to a ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... was valued at USD 12,212.9 million in 2013 and ... at a CAGR of 7.2% from 2014 to 2020. ... properties of light within specific electromagnetic spectrum to identify ...
(Date:9/15/2014)... New York (PRWEB) September 15, 2014 ... in U.S. courts, Bernstein Liebhard LLP notes that a ... be useful in curbing aggression in children with ADHD ... and parent training in behavioral management techniques. According to ... children with ADHD and aggression problems, half of whom ...
(Date:9/15/2014)... Adding chest radiation to chemotherapy allows some people with ... rates by nearly 50 percent, European researchers report. ... researchers recommended that chest radiotherapy be routinely offered to ... chemotherapy. , , Small-cell lung cancer (SCLC) is an ... 13 percent of all lung cancers. For most people, ...
Breaking Medicine News(10 mins):Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 2Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 3Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 2Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 3Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 4Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 5Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 2Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 3Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 4Health News:Chest Radiation May Help Fight Some Advanced Lung Cancers: Study 2Health News:Chest Radiation May Help Fight Some Advanced Lung Cancers: Study 3
... finds these doctors have better results, including survival rates ... surgeons may be the best choice for adults requiring ... study suggests. , A congenital heart defect occurs when ... vessels near the heart. , The researchers analyzed a ...
... researchers from,Wayne State University, in collaboration with Basrah Medical ... New Iraqi Journal of,Medicine today on war-related mental health ... Bengt B. Arnetz, Ph.D., professor of Family Medicine and ... State University led the team,of researchers to conduct a ...
... cardiac valves years later , , FRIDAY, Nov. 7 (HealthDay News) ... help fight obesity has been tied to heart value damage ... a new study reports. , The appetite suppressant fenfluramine ... of its links to heart damage. Thousands of lawsuits have ...
... Triple-S,Management Corporation (NYSE: GTS ) today ... Officer, and Juan-Jose Roman,Finance Vice President & CFO, ... Credit Suisse 2008 Healthcare Conference in Phoenix on,November ... presentation will be,broadcast live through the Internet. You ...
... by a tumor or injury carry a severe psychological and ... in plastic surgery. Helmut Fischer and Wolfgang Gubisch present the ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... a woman who had had a tumor removed from the ...
... Events Held in Los Angeles Area Enable Medicare,Beneficiaries ... Period, SAN FRANCISCO, Nov. 7 Helping ... of California is offering,free "Fitness and Flexibility" events ... month. The events will offer a demonstration of ...
Cached Medicine News:Health News:Pediatric Heart Surgeons May Be Best Choice for Adults 2Health News:First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq 2Health News:Banned Obesity Drug Tied to Heart Risks Long After Use 2Health News:Triple-S Management Corporation to Present at Credit Suisse 2008 Healthcare Conference 2Health News:Medicare Beneficiaries Can Suit Up, Sweat, and Learn About Blue Shield's Medicare Advantage Plans at Local Malls and Senior Centers 2Health News:Medicare Beneficiaries Can Suit Up, Sweat, and Learn About Blue Shield's Medicare Advantage Plans at Local Malls and Senior Centers 3Health News:Medicare Beneficiaries Can Suit Up, Sweat, and Learn About Blue Shield's Medicare Advantage Plans at Local Malls and Senior Centers 4Health News:Medicare Beneficiaries Can Suit Up, Sweat, and Learn About Blue Shield's Medicare Advantage Plans at Local Malls and Senior Centers 5
(Date:9/15/2014)... HONOLULU , Sept. 15, 2014  Patients in ... specialty care more frequently in an outpatient setting versus ... the curve and to ensure that patients continue to ... today the launch of its new internal medicine residency ... practice more often in office, clinic and even virtual ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- Asthma ... persons of all ages, but most commonly starts ... characterized by narrowing of the airways, leading to ... lungs come into contact with endogenous and exogenous ... events, such as swelling of the airways, tightening ...
(Date:9/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... owned subsidiary, Valeant Pharmaceuticals International, will redeem all of ... 6.75% Senior Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 ... has mailed an irrevocable notice of redemption for the ... of the irrevocable notice of redemption with respect to ...
Breaking Medicine Technology:Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
... to bring efficiency and quality to routine ... superior technology of fluorescent flow cytometry with ... sampling or batch processing are easily accommodated ... in high volume laboratories. Fluorescent flow ...
... The iQ200 System incorporates the ... and the AUTION MAX™ AX-4280 Automated ... a fully integrated chemical and microscopic ... (APR™), a well trained neural network, ...
... UF-100 is designed to bring efficiency and ... It combines the superior technology of fluorescent ... analysis. Continuous sampling or batch processing ... streamlining sample processing in high volume laboratories. ...
Medicine Products: